Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Xenetic Biosciences Plc
Pharmaceutical Preparations United Kingdom
London Stock Exchange: XEN
Xenetic Biosciences Plc is a biopharmaceutical company which develops vaccine delivery systems and various products in the fields of protein drugs, vaccines, and anti-cancer drugs. The company is engaged in designing and developing various technology platforms and clinical programmes. Xenetic's technologies are designed to improve the efficacy, safety, stability, biological half-life and immunologic characteristics of its products using its three proprietary patented technology platforms which include PolyXen, ImuXen and OncoHist. The company has multiple drug and vaccine programmes with three products which are currently in human clinical development with include ErepoXen, OncoHist and SuliXen. It was founded by Gregory Gregoriadis in 1997 and is headquartered in London, the United Kingdom.
Similar to: Trius Therapeutics, Inc., Mast Therapeutics, Inc., Sanofi
×We're Sorry! We do not have any documents available for this company. Tell us you want them!
St. Helier, JE, GB
NATURE GROUP is the market leader in handling Marpol and offshore waste, with more than 25 years’ collection and treatment experience.… Learn more →
You may also be interested in:
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →
San Diego, CA, US
Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company is leveraging… Learn more →
San Diego, CA, US
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →